HURRY!!! Today 11.20.2024 - Understanding Telehealth Induction with Methadone and Buprenorphine in OTPs Under the New SAMHSA Regulations 

Understanding Telehealth Induction with Methadone and Buprenorphine in OTPs Under the New SAMHSA Regulations 

November 20, 2024 from 12:30 PM - 2:00 PM EST.

NACDN was given late permission to share this event with others. Please follow link to register for this complimentary event from AATOD.  There are no continuing education credit announced for this event. Speakers include Mark Parrino, MPA - AATOD President and Neeraj Gandrotra, MD - Chief Medical Officer for SAMSHA.

When registering you may need to remove auto-populated info for (Susan Doyle) and fill in with your own.

https://us02web.zoom.us/webinar/register/WN_JTytsWa4TAeowW6q1SjCGg#/registration

From original email from Mark Parrino - AATOD President:

As many people in our field know, the new SAMHSA regulations for Opioid Treatment Programs (OTPs) was implemented on October 2, 2024. A number of OTPs have raised questions about who can conduct telehealth admissions to OTPs using methadone and buprenorphine. Mark Parrino, AATOD President, will serve as the host of this webinar along with principal speaker, Dr. Neeraj Gandotra, Chief Medical Officer for SAMHSA.

 

We are extremely grateful to have SAMHSA’s support in explaining how OTPs can fully utilize this new opportunity as a method of increasing access to treatment within the OTP setting. Please join us for this free webinar and we look forward to providing additional information about treating our patients.

 

There will be ample time for Q&A and this webinar will become available to the public for On-Demand viewing via the AATOD website. Please send an email if you have any questions about this approaching webinar opportunity.